Skip links

EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, October 26–28, 2022

Meet our CTO, Alexander Schinagl at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, October 26–28, in Barcelona. Alexander will present a poster (#347) on antitumorigenic activities of ON203 in preclinical models.

Home